Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human IL-26/AK155 Monomer Protein

Catalog No. p-4720070
Click to view available options
Formulation:
Supplied as a 0.2 μm filtered solution in NaH 2 PO 4 NaCl and Glycerol with BSA as a carrier protein.
Supplied as a 0.2 μm filtered solution in NaH 2 PO 4 NaCl and Glycerol.
This item is not returnable. View return policy
This item is not returnable. View return policy

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-26/AK155 Monomer Protein is derived from E. coli. The Recombinant Human IL-26/AK155 Monomer Protein has been validated for the following applications: Bioactivity.

Specifications

Formulation Supplied as a 0.2 μm filtered solution in NaH 2 PO 4 NaCl and Glycerol with BSA as a carrier protein.
Gene ID (Entrez) 55801
Molecular Weight (g/mol) 17.7 kDa
Name IL-26/AK155 Monomer
Quantity 25 μg
Source E. coli-derived human IL-26/AK155 protein Lys22-Gln171,with an N-terminal Met
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening.
Structural Form Monomer and a small amount of disulfide-linked homodimer (no more than 7%)
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.